Doç. Dr. Emin GEMCİOĞLU

1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

SOLMAZ İ., Kırık A., DEMİR İ., DİZDAR O. S., Gözel N., TAZEGÜL G., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

2. Independent and Combined Effects of Type 2 Diabetes Mellitus and Inappropriate Medication Use on Fall Risk among the Older People

Diker Çalış H. K., Güç Suvak Ö., GEMCİOĞLU E., AYPAK C.

Gerontology , cilt.72, sa.5, ss.331-342, 2026 (SCI-Expanded, Scopus)

3. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

SÜMBÜL H. E., Kirik A., Yaylaci S., Oral A., Serin S. O., Issever K., et al.

Hepatology International , 2026 (SCI-Expanded, Scopus)

4. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

Kirik A., SÜMBÜL H. E., KOCA N., PAŞALI KİLİT T., Demiral Sezer S., Binnetoglu E., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

5. Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observations

Erdogan B., ATA N., Caglayan M., GÖZÜKARA M. G., GEMCİOĞLU E., Sokmen F. C., et al.

Therapeutic Apheresis and Dialysis , cilt.28, sa.2, ss.265-271, 2024 (SCI-Expanded, Scopus)

6. Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system

YILMAZ ÇAKMAK N., ATA N., Güven S. C., GEMCİOĞLU E., Çağlayan M., Ülgü M., et al.

Turkish Journal of Medical Sciences , cilt.54, sa.5, ss.1005-1012, 2024 (SCI-Expanded, Scopus, TRDizin)

7. Is using inhaled corticosteroid effective against COVID-19 pneumonia severity and mortality? İnhale kortikosteroid kullanımı, COVID-19 pnömoni ağırlığı ve mortalitesin-de etkili midir?

KILIÇ H., ARGÜDER E., Civak M., GEMCİOĞLU E., KAYA KALEM A., HASANOĞLU İ., et al.

Tuberkuloz ve Toraks , cilt.72, sa.3, ss.219-228, 2024 (ESCI, Scopus, TRDizin)

8. Impact of celiac disease in Behçet’s syndrome patients: a study based on the database of Türkiye

YILMAZ ÇAKMAK N., ATA N., Güven S. C., GEMCİOĞLU E., Ülgü M. M., Birinci Ş.

Turkish Journal of Medical Sciences , cilt.54, sa.3, ss.493-501, 2024 (SCI-Expanded, Scopus, TRDizin)

9. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

ATEŞ İ., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.

Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)

10. Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients

KILIÇ H., ARGÜDER E., KARALEZLİ A., ÜNSAL E., GÜNER H. R., Kayaslan B., et al.

Frontiers in Medicine , cilt.9, 2022 (SCI-Expanded, Scopus)

11. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

KÜÇÜKŞAHİN O., ERDEN A., Karakaş Ö., Güven S. C., Armağan B., Şahiner E. S., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1486-1494, 2022 (SCI-Expanded, Scopus, TRDizin)

12. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

OMMA A., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.

Human Vaccines and Immunotherapeutics , cilt.18, sa.6, 2022 (SCI-Expanded, Scopus)

13. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

GÜNER H. R., KAYAASLAN B., HASANOĞLU İ., Aypak A., BODUR H., ATEŞ İ., et al.

BMC Infectious Diseases , cilt.21, sa.1, 2021 (SCI-Expanded, Scopus)

14. Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients

San I., GEMCİOĞLU E., BAŞER S., Yilmaz Cakmak N., ERDEN A., İZDEŞ S., et al.

Scientific Reports , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus)

15. Role of lung ultrasonography in the diagnosis of COVID-19 patients admitted to the emergency department Rolle des Lungenultraschalls bei der COVID-19-Diagnostik in der Notaufnahme

Şan İ., BEKGÖZ B., Usul E., YILDIRIM Ç., GEMCİOĞLU E., Kahraman A. F., et al.

Notfall und Rettungsmedizin , cilt.24, ss.15-20, 2021 (SCI-Expanded, Scopus)

16. Transport of awake hypoxemic probable COVID 19 patients in the prone position

Şan İ., YILDIRIM Ç., BEKGÖZ B., GEMCİOĞLU E.

American Journal of Emergency Medicine , cilt.46, ss.420-423, 2021 (SCI-Expanded, Scopus)

17. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?

Şan I., GEMCİOĞLU E., Davutoğlu M., Çatalbaş R., Karabuğa B., Kaptan E., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.6, ss.2810-2821, 2021 (SCI-Expanded, Scopus, TRDizin)

18. Evaluation of inflammatory rheumatic diseases from an emergency medicine perspective

San I., ERDEN A., GEMCİOĞLU E., KÜÇÜKŞAHİN O.

International Journal of Rheumatic Diseases , cilt.23, sa.12, ss.1670-1675, 2020 (SCI-Expanded, Scopus)

Doç. Dr. Emin GEMCİOĞLU

Yayınlar & Eserler

1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

2. Independent and Combined Effects of Type 2 Diabetes Mellitus and Inappropriate Medication Use on Fall Risk among the Older People

3. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

4. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

5. Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observations

6. Gastrointestinal bleeding among oral anticoagulant users: a comprehensive 7-year retrospective review using Türkiye’s national health data system

7. Is using inhaled corticosteroid effective against COVID-19 pneumonia severity and mortality? İnhale kortikosteroid kullanımı, COVID-19 pnömoni ağırlığı ve mortalitesin-de etkili midir?

8. Impact of celiac disease in Behçet’s syndrome patients: a study based on the database of Türkiye

9. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

10. Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients

11. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

12. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

13. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

14. Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients

15. Role of lung ultrasonography in the diagnosis of COVID-19 patients admitted to the emergency department Rolle des Lungenultraschalls bei der COVID-19-Diagnostik in der Notaufnahme

16. Transport of awake hypoxemic probable COVID 19 patients in the prone position

17. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?

18. Evaluation of inflammatory rheumatic diseases from an emergency medicine perspective

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim